Table 2.
Frequency of QIDS-SR16 Items at Baseline and Week 12 for Eligible Men Participating in Level 1 of STAR*D (n = 387).
| QIDS-SR16 items | Baseline, n (%) | Week 12, n (%) |
|---|---|---|
| Sleep-onset insomnia | 246 (63.6) | 125 (32.3) |
| Midnocturnal insomnia | 271 (70.0) | 237 (61.2) |
| Early morning insomnia | 180 (46.5) | 95 (24.6) |
| Hypersomnia | 38 (9.8) | 37 (9.6) |
| Sad mood | 312 (80.6) | 93 (24.0) |
| Decreased appetite | 80 (20.7) | 22 (5.7) |
| Increased appetite | 41 (10.6) | 25 (6.5) |
| Decreased weight | 52 (13.4) | 11 (2.8) |
| Increased weight | 27 (7.0) | 18 (4.7) |
| Impaired concentration | 220 (56.9) | 77 (19.9) |
| Negative view of self | 179 (46.3) | 65 (16.8) |
| Suicidal ideation | 51 (13.2) | 19 (4.9) |
| Lack of interest | 226 (58.4) | 70 (18.1) |
| Fatigue | 244 (63.1) | 69 (17.8) |
| Psychomotor retardation | 126 (32.6) | 46 (11.9) |
| Psychomotor agitation | 130 (33.6) | 59 (15.3) |
Note. QIDS-SR16 = Quick Inventory of Depressive Symptomatology; STAR*D = Sequenced Treatment Alternatives to Relieve Depression.